Gottlieb suggests human germline gene editing moratorium

FDA Commissioner Scott Gottlieb Wednesday asked Congress to fund the Trump administration’s request for $8.2 million in FY20 to enhance FDA’s regulatory oversight over gene editing.

Responding to questions at a House appropriations hearing, Gottlieb reiterated his concerns about allowing research on human germline editing (see “‘Tepid’ Response to CRISPR Embryo Editing Could Lead to Regulations, Gottlieb Says”)...